The Protective Effects of Beta-Casomorphin-7 against Glucose -Induced Renal Oxidative Stress In Vivo and Vitro

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Zhang, Wei ^a   Miao, Jinfeng ^a   Wang, Shanshan ^a   Zhang, Yuanshu ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; BETA CASOMORPHINE; BETA CASOMORPHINE 7; DIPEPTIDYL CARBOXYPEPTIDASE; GLUCAGON; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INSULIN; LOSARTAN; MALONALDEHYDE; STREPTOZOCIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BETA-CASOMORPHIN 7; ENDORPHIN; GLUCOSE BLOOD LEVEL; ISOENZYME; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLUCAGON BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; KIDNEY; KIDNEY PARENCHYMA; KIDNEY TUBULE CELL; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; RAT; RENAL PROTECTION; ANIMAL; BLOOD; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DRUG EFFECTS; EPITHELIUM CELL; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD GLUCOSE; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENDORPHINS; EPITHELIAL CELLS; GLUCAGON; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INSULIN; ISOENZYMES; KIDNEY; LOSARTAN; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE;

EID: 84877052600     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063472     Document Type: Article

References (41)

1. Zimmet P, Alberti K, Shaw J, (2001) Global and societal implications of the diabetes epidemic. Nature 414: 782-787.
2. Jones CA, Krolewski AS, Rogus J, Xue JL, Collins A, et al. (2005) Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? kidney international 67: 1684-1691.
3. Cooper ME, (1998) Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 352: 213-219.
4. Forbes JM, Coughlan MT, Cooper ME, (2008) Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 57: 1446-1454.
5. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
6. Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J, (2003) Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid. Free Radical Biology and Medicine 34: 186-195.
7. Gui D, Guo Y, Wang F, Liu W, Chen J, et al. (2012) Astragaloside IV, a novel antioxidant, prevents glucose-Induced podocyte apoptosis in vitro and in vivo. PLoS One 7: e39824.
8. Calderon-Salinas J, Munoz-Reyes E, Guerrero-Romero J, Rodriguez-Moran M, Bracho-Riquelme R, et al. (2011) Eryptosis and oxidative damage in type 2 diabetic mellitus patients with chronic kidney disease. Molecular and Cellular Biochemistry 357: 171-179.
9. Brantl V, Teschemacher H, Henschen A, Lottspeich F, (1979) Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. Hoppe Seylers Z Physiol Chem 360: 1211-1216.
10. Elliott R, Harris D, Hill J, Bibby N, Wasmuth H, (1999) Type I (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. Diabetologia 42: 292-296.
11. Song XD, ZUO WY, Fan YL, YS Z, (2009) Effect of β-casomorphin-7 from milk on the absorption of glucose in vitro and its mechanism. world journal of gastroenterology pp. pp. 1947-1951.
12. Yin H, Miao J, Zhang Y, (2010) Protective effect of beta-casomorphin-7 on type 1 diabetes rats induced with streptozotocin. Peptides 31: 1725-1729.
13. Zhang W, Miao J, Ma C, Han D, Zhang Y, (2012) beta-Casomorphin-7 attenuates the development of nephropathy in type I diabetes via inhibition of epithelial-mesenchymal transition of renal tubular epithelial cells. Peptides 36: 186-191.
14. Soulis-Liparota T, Cooper M, Papazoglou D, Clarke B, Jerums G, (1991) Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes 40: 1328-1334.
15. Neuhoff V, Arold N, Taube D, Ehrhardt W, (1988) Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9: 255-262.
16. MARKLUND S, MARKLUND G, (2005) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European Journal of Biochemistry 47: 469-474.
17. Nishikimi M, Appaji Rao N, Yagi K, (1972) The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochemical and Biophysical Research Communications 46: 849-854.
18. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ, (1984) Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Research 44: 5086-5091.
19. Flohe L, Gunzler WA, (1984) Assays of glutathione peroxidase. Methods in Enzymology 105: 114-121.
20. Draper H, Hadley M, (1990) Malondialdehyde determination as index of lipid peroxidation. Methods in Enzymology 186: 421-431.
21. Janero DR, (1990) Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biology and Medicine 9: 515-540.
22. Placer ZA, Cushman LL, Johnson BC, (1966) Estimation of product of lipid peroxidation (malonyl dialdehyde) in biochemical systems. Analytical Biochemistry 16: 359.
23. Boveris A, (1984) Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria. Methods in Enzymology 105: 429-435.
24. Zhou Q, Liu K, Wu H, Chen L, Pouranan V, et al. (2012) Spironolactone Rescues Dot1a-Af9-Mediated Repression of Endothelin-1 and Improves Kidney Injury in Streptozotocin-Induced Diabetic Rats. PloS one 7: e47360.
25. DeRubertis FR, Craven PA, Melhem MF, Salah E, (2004) Attenuation of renal injury in db/db mice overexpressing superoxide dismutase-Evidence for reduced superoxide-nitric oxide interaction. Diabetes 53: 762-768.
26. Lakshmanan AP, Watanabe K, Thandavarayan RA, Sari FR, Harima M, et al. (2011) Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action. Free Radical Research 45: 575-584.
27. Giacco F, Brownlee M, (2010) Oxidative stress and diabetic complications. Circulation Research 107: 1058-1070.
28. Yamagishi S, Matsui T, (2010) Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxidative Medicine and Cellular Longevity 3: 101-108.
29. Takayanagi R, Inoguchi T, Ohnaka K, (2011) Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus. Journal of clinical biochemistry and nutrition 48: 72-77.
30. Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P, (1997) Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clinical Chemistry 43: 1209-1214.
31. Jain SK, Levine SN, Duett J, Hollier B, (1990) Elevated lipid peroxidation levels in red blood cells of streptozotocin-treated diabetic rats. Metabolism: Clinical and Experimental 39: 971-975.
32. Makni M, Sefi M, Fetoui H, Garoui EM, Gargouri NK, et al. (2010) Flax and Pumpkin seeds mixture ameliorates diabetic nephropathy in rats. Food and Chemical Toxicology 48: 2407-2412.
33. Brantl V, (1984) Novel opioid peptides derived from human beta-casein: human beta-casomorphins. Eur J Pharmacol 106: 213-214.
34. Chang SY, Chen YW, Chenier I, Tran Sle M, Zhang SL, (2011) Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. Experimental Diabetes Research 2011: 521076.
35. Oudit GY, Herzenberg AM, Kassiri Z, Wong D, Reich H, et al. (2006) Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. American Journal of Pathology 168: 1808-1820.
36. Griendling KK, Ushio-Fukai M, (2000) Reactive oxygen species as mediators of angiotensin II signaling. Regulatory Peptides 91: 21-27.
37. Kim S-M, Kim Y-G, Jeong K-H, Lee S-H, Lee T-W, et al. (2012) Angiotensin II-Induced Mitochondrial Nox4 Is a Major Endogenous Source of Oxidative Stress in Kidney Tubular Cells. Plos One 7.
38. Kedziora-Kornatowska K, Luciak M, Paszkowski J, (2008) Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors. IUBMB life 49: 303-307.
39. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS, (2002) Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney International 61: 186-194.
40. Ott IM, Alter ML, von Websky K, Kretschmer A, Tsuprykov O, et al. (2012) Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade. PloS one 7.
41. Liu CX, Hu Q, Wang Y, Zhang W, Ma ZY, et al. (2011) Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition. Molecular Medicine 17: 59-69.